On behalf of the UW Health Blood and Bone Marrow Transplant Program, Peiman Hematti, MD (pictured at upper right), professor, and Natalie Callendar, MD (pictured at lower right), professor (CHS), both of Hematology, Medical Oncology and Palliative Care, will serve on the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Steering Committee. 

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) was established in 2001 to meet a critical need for multi-institutional clinical trials focused directly on improving survival for patients undergoing hematopoietic cell transplantation (HCT). Since 2001, the organization has opened more than 30 multi-institutional Phase II and III trials, involved more than 100 transplant centers, and enrolled thousands of patients.

The Steering Committee sets the scientific agenda and oversees the selection, design, execution, and analysis of all BMT CTN studies.

Because of the number of patients at UW Health enrolled in BMT CTN clinical trials from July 1, 2016 to June 30, 2017, UW Health's program was selected as an Affiliate Center that meets the organization's standards for exemplary accrual and trial participation. 

Resources: 

• Blood and Marrow Transplant Clinical Trials Network
• UW Health Blood and Bone Marrow Transplant Program